Tectonic Therapeutic (TECX) Cash & Current Investments (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Cash & Current Investments data on file, last reported at $236.9 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $236.9 million, down 22.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $236.9 million (down 22.65% YoY), and the FY2025 annual result was $254.4 million, up 80.11% from the prior year.
• Cash & Current Investments slipped to $236.9 million in Q1 2026 per TECX's latest filing, from $254.4 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $306.2 million in Q1 2025 and troughed at $6.6 million in Q3 2023.
• A 5-year average of $146.2 million and a median of $141.2 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2024: Cash & Current Investments tumbled 94.32% in 2023, then jumped 2305.79% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $92.8 million in 2022, then tumbled by 68.71% to $29.1 million in 2023, then jumped by 386.16% to $141.2 million in 2024, then jumped by 80.11% to $254.4 million in 2025, then declined by 6.88% to $236.9 million in 2026.
• Business Quant data shows TECX's Cash & Current Investments at $236.9 million in Q1 2026, $254.4 million in Q4 2025, and $269.0 million in Q3 2025.